Eric is an Associate at Cowen Healthcare Investments. He currently serves as a Board Director or Observer for Escient Pharmaceuticals, Aro Biotherapeutics, and Arch Oncology. Before joining Cowen, he was most recently a Senior Analyst on the investment team at Roivant Sciences, where he evaluated business development opportunities to build the company’s therapeutics portfolio. Eric received his B.A. in Molecular and Cell Biology from the University of California, Berkeley and a Ph.D. in Molecular and Cell Biology from the University of Houston.
Likes
Share It 
